P38 kinase inhibiting agents

Compounds described by the chemical formula (1) or pharmaceutically acceptable salts thereof: are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN, MENG-HSIN, MEINKE, PETER T, KOYAMA, HIROO, DYKSTRA, KEVIN D, YANG, GINGER XU-QIANG, SAHOO, SOUMYA P, O'KEEFE, STEPHEN J
Format Patent
LanguageChinese
English
Published 16.12.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Compounds described by the chemical formula (1) or pharmaceutically acceptable salts thereof: are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.
AbstractList Compounds described by the chemical formula (1) or pharmaceutically acceptable salts thereof: are inhibitors of p38 and are useful in the treatment of inflammation such as in the treatment of asthma, COPD, ARDS, rheumatoid arthritis, rheumatoid spondylitis, osteoarthritis, gouty arthritis and other arthritic conditions; inflamed joints, eczema, psoriasis or other inflammatory skin conditions such as sunburn; inflammatory eye conditions including conjunctivitis; pyresis, pain and other conditions associated with inflammation.
Author O'KEEFE, STEPHEN J
CHEN, MENG-HSIN
KOYAMA, HIROO
SAHOO, SOUMYA P
YANG, GINGER XU-QIANG
MEINKE, PETER T
DYKSTRA, KEVIN D
Author_xml – fullname: CHEN, MENG-HSIN
– fullname: MEINKE, PETER T
– fullname: KOYAMA, HIROO
– fullname: DYKSTRA, KEVIN D
– fullname: YANG, GINGER XU-QIANG
– fullname: SAHOO, SOUMYA P
– fullname: O'KEEFE, STEPHEN J
BookMark eNrjYmDJy89L5WSQCTC2UMjOzEssTlXIzMvITMosycxLV0hMT80rKeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGBpamhobGxo7GxKgBAD4rJSI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW200951133A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW200951133A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:58:05 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW200951133A3
Notes Application Number: TW200998118954
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091216&DB=EPODOC&CC=TW&NR=200951133A
ParticipantIDs epo_espacenet_TW200951133A
PublicationCentury 2000
PublicationDate 20091216
PublicationDateYYYYMMDD 2009-12-16
PublicationDate_xml – month: 12
  year: 2009
  text: 20091216
  day: 16
PublicationDecade 2000
PublicationYear 2009
RelatedCompanies MERCK & CO., INC
RelatedCompanies_xml – name: MERCK & CO., INC
Score 2.862258
Snippet Compounds described by the chemical formula (1) or pharmaceutically acceptable salts thereof: are inhibitors of p38 and are useful in the treatment of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title P38 kinase inhibiting agents
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20091216&DB=EPODOC&locale=&CC=TW&NR=200951133A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTNLTEqzME7VTTEzT9U1SU1K1k2yNEvWTTYFtkYsDVINkpLAq3z9zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3bGloZGim5uJk6xrg7-LvrObsbBsSruYXBJYDti2MjR2ZGViBzWhzUG5wDXMC7UopQK5S3AQZ2AKApuWVCDEwVWUIM3A6w25eE2bg8IVOeAOZ0LxXLMIgE2BsoZCdmQesdhQy8zIykzJBK5YVEkF7o4pFGRTdXEOcPXSB1sTD_RQfEo5wkbEYAwuwr58qwaCQaJlmYpRomZyYYmwM7GqlJIEqj1RLk8Q0szRLUwMDSQYp3OZI4ZOUZuAygl59YGgmw8BSUlSaKgusT0uS5MABAQCCPHk0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTNLTEqzME7VTTEzT9U1SU1K1k2yNEvWTTYFtkYsDVINkpLAq3z9zDxCTbwiTCOYGLJge2HA54SWgw9HBOaoZGB-LwGX1wWIQSwX8NrKYv2kTKBQvr1biK2LGqx3bGloZGim5uJk6xrg7-LvrObsbBsSruYXBJYDti2MjR2ZGViBTWxzUG5wDXMC7UopQK5S3AQZ2AKApuWVCDEwVWUIM3A6w25eE2bg8IVOeAOZ0LxXLMIgE2BsoZCdmQesdhQy8zIykzJBK5YVEkF7o4pFGRTdXEOcPXSB1sTD_RQfEo5wkbEYAwuwr58qwaCQaJlmYpRomZyYYmwM7GqlJIEqj1RLk8Q0szRLUwMDSQYp3OZI4ZOUZ-D0CPH1iffx9POWZuAygl6DYGgmw8BSUlSaKgusW0uS5MCBAgBbqXwn
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=P38+kinase+inhibiting+agents&rft.inventor=CHEN%2C+MENG-HSIN&rft.inventor=MEINKE%2C+PETER+T&rft.inventor=KOYAMA%2C+HIROO&rft.inventor=DYKSTRA%2C+KEVIN+D&rft.inventor=YANG%2C+GINGER+XU-QIANG&rft.inventor=SAHOO%2C+SOUMYA+P&rft.inventor=O%27KEEFE%2C+STEPHEN+J&rft.date=2009-12-16&rft.externalDBID=A&rft.externalDocID=TW200951133A